Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2
Martin Friedlander, MD, PhD
Advertisement
Articles by Martin Friedlander, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
2
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
3
FLORetina 2025: New horizons in research and risk management for ROP
4
FLORetina 2025: Artificial intelligence at the frontlines of ROP care
5
